Full Length Article|
Open Access
|Issue|Published: 23 October 2022
Downregulated nuclear lncRNA NRON inhibits SHP2/Wnt/β-catenin signaling and cardiomyocyte differentiation during the development of Tetralogy of Fallot
Show Author's Information
Hide Author's Information
Hui Zhanga,b,, Lei Luc, Chao Lid, Hongdou Lid, Jie Tianb(
), Hongyan Wangc,d(
)
Zhang Zhongjing School of Chinese Medicine; Henan Key Laboratory of Zhang Zhongjing Formulae and Herbs for Immunoregulation, Nanyang Institute of Technology, Nanyang, Henan 473004, China
Department of Cardiology, Heart Centre; Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical Research Center for Child Health and Disorders; Chongqing Key Laboratory of Pediatrics China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Children's Hospital of Chongqing Medical University, Chongqing 400014, China
Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Fudan University, Shanghai 200011, China
Obstetrics and Gynecology Hospital, NHC Key Laboratory of Reproduction Regulation, Shanghai Institute of Planned Parenthood Research, State Key Laboratory of Genetic Engineering at School of Life Sciences, Children's Hospital, Fudan University, Shanghai 200438, China
Peer review under responsibility of Chongqing Medical University.
Cite this article:
Zhang H, Lu L, Li C, et al. Downregulated nuclear lncRNA NRON inhibits SHP2/Wnt/β-catenin signaling and cardiomyocyte differentiation during the development of Tetralogy of Fallot. Genes & Diseases, 2023, 10(3): 750-752. https://doi.org/10.1016/j.gendis.2022.10.010